Live Breaking News & Updates on Biotechnologies Stock Down

Stay updated with breaking news from Biotechnologies stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Given Consensus Recommendation of "Moderate Buy" by Analysts

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Given Consensus Recommendation of "Moderate Buy" by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Wells Fargo Company , Vivo Capital , Cantor Fitzgerald , Gracell Biotechnologies Inc , Oasis Management Co Ltd , Bellevue Group , Venture Partners Investment Advisor , Gracell Biotechnologies , Get Free Report , Marketbeat Ratings , Asset Management , Biotechnologies Stock Down , Get Free , Biotechnologies Inc , Gracell Biotechnologies Daily ,

Commodore Capital LP Grows Stock Position in Adverum Biotechnologies, Inc. (NASDAQ:ADVM)

Commodore Capital LP grew its holdings in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 100.0% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,000,000 shares of the biotechnology company’s stock after purchasing an additional 5,000,000 shares during the quarter. Adverum […] ....

Invesco Ltd , Securities Exchange Commission , Adverum Biotechnologies Inc , Mirabella Financial Services , Adverum Biotechnologies Company Profile , York Mellon Corp , Commodore Capital , Adverum Biotechnologies , Free Report , Financial Services , Street Group , New York Mellon Corp , Biotechnologies Stock Down , Get Free Report , Visit Holdingschannel , Adverum Biotechnologies Daily , Nasdaq Advm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Commodore Capital LP Makes New Investment in Adverum Biotechnologies, Inc. (NASDAQ:ADVM)

Commodore Capital LP acquired a new position in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,000,000 shares of the biotechnology company’s stock, valued at approximately $3,587,000. Adverum Biotechnologies accounts for 0.5% […] ....

Adverum Biotechnologies Company Profile , Adverum Biotechnologies Inc , Cm Management , Millennium Management , Exchange Commission , Capital Management , Marshall Wace , Renaissance Technologies , Commodore Capital , Adverum Biotechnologies , Free Report , Biotechnologies Stock Down , Get Free Report , Adverum Biotechnologies Daily , Nasdaq Advm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Adverum Biotechnologies (NASDAQ:ADVM) Stock Rating Reaffirmed by Truist Financial

Truist Financial restated their buy rating on shares of Adverum Biotechnologies (NASDAQ:ADVM – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. Other equities analysts have also issued research reports about the stock. StockNews.com initiated coverage on shares of Adverum Biotechnologies […] ....

United States , Adverum Biotechnologies Inc , Vr Adviser , America Corp , Capital Management , Truist Financial , Adverum Biotechnologies , Free Report , Moderate Buy , Biotechnologies Stock Down , Get Free Report , Adverum Biotechnologies Daily , Nasdaq Advm , Reiterated Rating , Truist Financial Co ,